Despite growing competition from larger medtechs, Dexcom, Insulet and Tandem all boosted revenue targets for the year on significant expansion of insulin delivery systems and continuous glucose monitors in the first quarter.
Source: Healthcare Dive, https://www.healthcaredive.com